Trudy from Luxembourg

Registered at the short selling broker IQ Option, 3 minutes ago.

» Try IQ Option you too
87% of retail investor accounts lose money when trading CFDs with IQ Option.
Don't show again

GlaxoSmithKline Plc (GSK) shares information

Glaxosmithkline plc – ADR


24h Change

0.56 %

GSK

Live rate: Market closed

Stock data per Friday 22 Oct, 2021

GSK
NEW YORK STOCK EXCHANGE INC.
39.55
39.63
39.77
0.22 (+ 0.56%)
US Market is closed

Live Stock price in graph for Glaxosmithkline plc – ADR (GSK)

  • Latest Volume

    4,841,180 (-7.02 %)

  • Volume prev. day

    5,206,530

  • Avg. daily volume

    4,083,198

  • Market cap

    100,042,950,118

  • P/E ratio

    15.36

  • Today high

    39.81 USD

  • Today low

    39.59 USD

  • 52 week high

    42.14 USD

  • 52 week low

    31.43 USD

  • YTD Change

    + 13.47 %

Quick links

 

Latest news about Glaxosmithkline plc – ADR

Below you can find the most recent news posts about Glaxosmithkline plc – ADR, primarily from US and UK based news sources.

GlaxoSmithKline plc (NYSE:GSK) Stake Lowered by Baldwin Investment Management LLC

Saturday, 23 October 2021, 13:58:46
Baldwin Investment Management LLC reduced its stake in shares of GlaxoSmithKline plc (NYSE:GSK) by 9.9% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,408 shares of the pharmaceutical companys stock after selling 592 shares during the period. Baldwin Investment Management []
— Transcript Daily


Travel Vaccines Market Is Booming Worldwide with Pfizer, Sanofi, GlaxoSmithKline, Merck

Saturday, 23 October 2021, 07:07:20
Advance Market Analytics published a new research publication on Travel Vaccines Market Insights, to 2026 with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities
— OpenPR


Silvercrest Asset Management Group LLC Sells 3,900 Shares of GlaxoSmithKline plc (NYSE:GSK)

Friday, 22 October 2021, 17:34:49
Silvercrest Asset Management Group LLC lowered its stake in shares of GlaxoSmithKline plc (NYSE:GSK) by 0.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 465,062 shares of the pharmaceutical companys stock after selling 3,900 shares during the quarter. Silvercrest Asset Management Group LLCs holdings []
— Transcript Daily


Nasal Drug Delivery Systems Market 2028 Rising Demand and International Forecast Scope Led by Top Key Players Merck & Co., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson

Friday, 22 October 2021, 10:56:48
Nasal Drug Delivery Systems Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading
— OpenPR


GlaxoSmithKline (LON:GSK) Given New GBX 1,540 Price Target at Berenberg Bank

Friday, 22 October 2021, 08:26:41
GlaxoSmithKline (LON:GSK) had its price target decreased by Berenberg Bank from GBX 1,625 ($21.23) to GBX 1,540 ($20.12) in a report issued on Monday, Analyst Ratings Network reports. Berenberg Bank currently has a buy rating on the stock. Several other equities research analysts have also recently issued reports on GSK. Morgan Stanley decreased their target []
— Dakota Financial News


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have GSK available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.